SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.37-8.4%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Edward Paule who wrote (10038)5/17/1999 3:07:00 PM
From: Cacaito  Read Replies (2) of 17367
 
Edward, you are right the lps is decreased, but how much is "free" vs bound to rBPI21 ?

And let's add CLEARANCE of lps is faster and more efficient with rBPI21.

I have being looking for the full article on this baboon beastness and BPI. Not at hand yet.

I did noticed the emphasis on antibacterial vs antiendotoxin, I think the final wording of the abstract is misleading at best, wrong at worst. But will reserve my final judgement for the time that I have the full article at hand.

If Bpi is not an inflammatory cascade regulator (besides its potent antibacterial effect), I will put all my money out right now.

Just killing bacteria is dumb bomb.

Many times there are no bacteria growing in blood and patients are "sterile" but the shock continues the same.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext